Who Is Dr. Erica Schwartz, Trump’s Powerful Pick to Lead the CDC?
Former Deputy Surgeon General Brings Medicine, Military Leadership and Law to a Public Health Agency Facing Political Pressure
President Donald Trump’s pick for CDC director, Dr. Erica Schwartz, is a physician, attorney and veteran federal health official who previously served as deputy U.S. surgeon general. Contrary to some early descriptions, Schwartz did not serve as deputy attorney general during Trump’s first term. Her nomination places an experienced public health leader at the center of a national debate over vaccines, scientific independence and the future of the Centers for Disease Control and Prevention.
Trump nominated Schwartz in April 2026. On July 30, the Senate Health, Education, Labor and Pensions Committee advanced her nomination, moving her closer to a vote by the full Senate. She has not yet been confirmed as of August 4, 2026.
Who Is Dr. Erica Schwartz?
Dr. Erica G. Schwartz is a board-certified preventive medicine physician with training in occupational and environmental medicine. She has also earned degrees in public health, biomedical engineering and law.
Her career has included leadership positions in the U.S. Navy, Coast Guard, U.S. Public Health Service and Department of Health and Human Services.
Her qualifications include:
- A bachelor’s degree in biomedical engineering from Brown University
- A medical degree from Brown University School of Medicine
- A Master of Public Health from the Uniformed Services University
- A law degree from the University of Maryland
- Admission to the District of Columbia Bar
- Board certification in preventive medicine
Schwartz also served as a Navy occupational medicine physician before joining the U.S. Public Health Service and Coast Guard in 2005.
Her résumé is unusual for a CDC nominee. It combines clinical medicine, public health, military command, government management and legal training.
That background could help her manage an agency that must respond to disease outbreaks while also navigating Congress, the White House, state governments and the Department of Health and Human Services.
Schwartz Was Deputy Surgeon General, Not Deputy Attorney General
The distinction is important.
The deputy attorney general is the second-highest official at the U.S. Department of Justice. That position deals with criminal law, federal prosecutions and law enforcement policy.
Schwartz instead served as deputy surgeon general, a senior public health position within the Department of Health and Human Services.
As deputy surgeon general, she worked with the Office of the Surgeon General to communicate health information, coordinate public health efforts and advise federal officials.
In a 2020 federal meeting on antimicrobial resistance, Schwartz was officially identified as “Deputy Surgeon General of the United States.” During that meeting, she discussed the danger posed by drug-resistant infections and the need for new medicines, diagnostic tools and preventive strategies.
She also held the rank of rear admiral in the U.S. Public Health Service Commissioned Corps.
A Career Built Around Public Health Emergencies
Schwartz’s federal career included work on several major health threats and national emergencies.
According to an official Coast Guard biography, she helped develop health protection guidance related to:
- Hurricanes Katrina and Rita
- The 2009 H1N1 influenza pandemic
- The 2010 Haiti earthquake response
- The Deepwater Horizon oil spill
- The Ebola outbreak in West Africa
- Pandemic influenza planning
- Anthrax and smallpox vaccination policies
- Communicable disease quarantine policies
She also helped establish disease surveillance, vaccination and medical readiness programs for Coast Guard personnel.
At the Coast Guard, Schwartz oversaw a health system that included 41 clinics and roughly 150 sick bays. Her responsibilities extended beyond medical treatment to workplace safety, child care, sexual assault prevention, substance abuse programs and health promotion.
That experience suggests she understands that public health involves more than responding to viruses. It also includes workplace safety, emergency planning, mental health, family support and access to reliable medical services.
Why Trump Selected Schwartz
When Trump announced the nomination, he described Schwartz as highly qualified. Her selection also appeared to be an attempt to bring stability to the CDC after repeated leadership changes and disputes over public health policy.
Schwartz was not Trump’s first choice during his second administration.
The administration considered or nominated other candidates before turning to Schwartz. The CDC also experienced leadership turnover and disagreements over vaccine policy, scientific authority and the agency’s relationship with HHS Secretary Robert F. Kennedy Jr.
Her traditional public health background sets her apart from some political figures who have challenged long-established vaccine recommendations.
Schwartz has publicly supported vaccines and evidence-based medicine. That position could reassure physicians and public health researchers. It could also create tension with officials who want major changes to federal vaccine policy.
What Schwartz Said About Vaccines
Vaccines became one of the central issues at Schwartz’s July 15 Senate confirmation hearing.
She told senators that she supports vaccines and believes medical decisions should be based on scientific evidence. She also described her upbringing in a military family and emphasized her record of public service.
However, some lawmakers wanted clearer answers about whether she would resist political pressure from Kennedy or the White House.
Schwartz did not give a direct promise that she would publicly defy the administration if she believed an order was scientifically unsound. That concerned senators and public health advocates who fear that CDC recommendations could be shaped by politics.
Supporters argue that nominees cannot reasonably promise in advance to oppose their supervisors on hypothetical questions. They say Schwartz’s long medical career and support for immunization provide evidence that she will defend science from within the administration.
Critics respond that the CDC director must be willing to speak plainly when public health evidence conflicts with political demands.
That debate is likely to continue if the Senate considers her nomination.
Why the CDC Director Matters
The CDC director oversees one of the most important public health institutions in the world.
The agency tracks infectious diseases, studies health threats, issues medical guidance and helps state and local officials respond to emergencies. It also monitors foodborne illnesses, workplace hazards, chronic diseases and emerging outbreaks.
In practical terms, the CDC director can influence:
- Vaccine recommendations
- Outbreak investigations
- Public health warnings
- Disease surveillance
- Emergency preparedness
- Guidance for doctors, schools and families
- Cooperation with state and local health departments
The CDC describes itself as a science-based, data-driven agency that works continuously to protect public health.
The director must therefore maintain public trust while managing a large federal workforce and responding quickly to new threats.
That job becomes harder when Americans are deeply divided over vaccines, masking, government authority and the lessons of the COVID-19 pandemic.
Could Schwartz Become the First Black Woman to Lead the CDC?
If confirmed, Schwartz would become the first Black woman to serve as CDC director.
She would not be the first Black person to lead the agency. Dr. David Satcher served as CDC director from 1993 to 1998 and later became U.S. surgeon general.
The historic nature of Schwartz’s nomination matters, but representation alone will not determine her success.
She would be judged on whether she can:
- Restore confidence in CDC science
- Protect researchers from improper interference
- Communicate clearly during emergencies
- Strengthen disease surveillance
- Work with state and local health agencies
- Explain vaccine decisions transparently
- Maintain public access to credible health information
Support and Concerns Surrounding the Nomination
Schwartz has received support from Republicans who view her as an experienced and conventional public health professional.
Sen. Bill Cassidy of Louisiana, a physician who chairs the Senate health committee, supported advancing her nomination after reviewing her record and discussing his concerns with her. The committee vote moved the nomination to the next stage, although reports differed slightly on the exact tally. Reuters reported a 13-10 vote. Axios reported 12-10. Because of that discrepancy, the safest verified conclusion is that the committee approved the nomination on July 30.
Democrats and public health groups have focused on whether Schwartz will have genuine independence.
They want to know what she would do if instructed to weaken vaccine recommendations, suppress research or change scientific guidance without strong evidence.
Those are fair questions. The CDC director serves within a presidential administration, but the agency’s credibility depends on the public believing that health guidance is based on evidence rather than political convenience.
What Happens Next?
Schwartz still needs approval from the full Senate before she can become the permanent CDC director.
The Senate’s August recess could delay the final vote. Until confirmation occurs, she remains the nominee rather than the confirmed head of the agency.
Senators should closely examine her record, commitments and willingness to explain difficult decisions to the public.
The public should also pay attention. CDC leadership affects more than Washington politics. It influences how communities respond to measles, influenza, food contamination, antibiotic resistance and the next unexpected health emergency.
Dr. Erica Schwartz brings substantial experience in medicine, military health and federal service. Her record suggests she understands emergency preparedness and preventive medicine.
The larger question is whether she will have the independence and authority to place scientific evidence ahead of political pressure.
Americans should follow the Senate confirmation process, read the nominee’s testimony and demand transparency from every official responsible for protecting the nation’s health.
